How Bacteria Outsmart Disinfectants

Disinfectants induce oxidative damage in bacteria, but a single mutation triggers the expression of genes that help the microbe survive.

Sneha Khedkar
| 3 min read
Cleaning supplies in a basket against a neutral background.

Repeated exposure to disinfectants leads to a mutation in a bacterial enzyme that enhances survival.

©iStock, Anna Puzatykh

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Disinfectants such as bleach, acids, phenols, and alcohols are important weapons against infectious diseases. During the COVID-19 pandemic, as the coronavirus ran rampant across the world, experts advised disinfecting frequently touched surfaces to prevent viral transmission. Despite this, scientists do not completely understand how these compounds kill microbes or how microbes become tolerant to them.

Now, a research team led by Xilin Zhao at Xiamen University has found that a mutation in an enzyme in Escherichia coli helps the bacterium survive exposure to disinfectants.1 The results, published in Proceedings of the National Academy of Sciences, provide insights into how bacteria develop tolerance to disinfectants and pinpoint genes that can be surveyed for disinfectant tolerance in pathogens.

The researchers started out by using a strain of E. coli engineered to carry a mutation in a gene involved in the carbohydrate phosphotransferase system (PTS), which causes the bacterium to exhibit tolerance to some disinfectants, including phenols.2 Although an initial exposure to phenol wiped out many of the ptsI mutants, some of the bacteria survived subsequent treatment.

Sequencing the genome of the phenol-tolerant bacteria revealed a mutation in a subunit of the enzyme phenylalanine-tRNA synthetase (PheS), which is essential for protein synthesis. This mutation caused the amino acid phenylalanine to be replaced by cysteine at the 158th position in the protein (F158C). Introducing the pheS F158C mutation to wild type E. coli using CRISPR/Cas9 editing tools rendered them tolerant to several other disinfectants.

When Zhao and his team replaced phenylalanine with other amino acids besides cysteine, they found that the mutants still tolerated phenol, suggesting that the trait depends on the specific position rather than the amino acids.

The researchers speculated that a mutation at the 158th position may reduce PheS’s ability to recognize its substrate, phenylalanine. This would mimic conditions of phenylalanine starvation, which can trigger the accumulation of alarmones, “antideath” signaling molecules produced by bacteria in response to such stress. One alarmone implicated in antimicrobial resistance is guanosine pentaphosphate (ppGpp).3 Introducing the mutation to an E. coli strain that cannot synthesize ppGpp eliminated phenol tolerance, confirming that the mutation acts through the alarmone.

Further experiments revealed that the alarmone triggers a cascade of events that culminates in the transcription of genes that suppress reactive oxygen species (ROS), which trigger bacterial death.4 Consistent with this, Zhao and his team observed that disinfectant exposure caused a surge in E. coli ROS levels and that this surge was reduced in the mutant strain.

Finally, the researchers investigated the clinical significance of their results. When they introduced an F158C mutation in the PheS of pathogenic Klebsiella pneumoniae and enterohemorrhagic E. coli, bacterial strains that commonly cause disease in people, the mutants exhibited tolerance to disinfectants.

Follow-up investigations should examine whether mutations in additional aminoacyl-tRNA synthetases result in similar disinfectant tolerance in bacteria and whether other cellular pathways are involved in conferring this effect, the authors noted.

Keywords

Meet the Author

  • Sneha Khedkar

    Sneha Khedkar

    Sneha Khedkar is an Assistant Editor at The Scientist. She has a Master's degree in biochemistry and has written for Scientific American, New Scientist, and Knowable Magazine, among others.
Share
You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide